meta_analysis
    2020
    High Quality

    Pine bark (Pinus spp.) extract for treating chronic disorders

    Robertson NU, Schoonees A, Brand A, Visser J

    Published in Cochrane Database of Systematic Reviews

    Methodology

    Cochrane systematic review of 27 randomized controlled trials of pine bark extract across chronic conditions including asthma, ADHD, cardiovascular disease, diabetes and osteoarthritis

    Key Findings

    Results were inconsistent across conditions and the certainty of evidence was very low for all outcomes; no condition showed reliable benefit

    Conclusions

    Current evidence is insufficient to support pine bark extract for any chronic disorder

    Limitations

    Small trials, high risk of bias, heavy manufacturer involvement, short durations

    Supplements Studied

    Results were inconsistent across conditions and the certainty of evidence was very low for all outcomes; no condition showed reliable benefit

    Outcomes Measured

    Results were inconsistent across conditions and the certainty of evidence was very low for all outcomes; no condition showed reliable benefit

    Related Health Concerns

    Study Details

    Year:2020
    Sample Size:1,641
    Quality Score:10/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.